HomeInsightsPE

Morepen Laboratories Ltd PE Ratio

Morepen Laboratories Ltd PE Ratio

stocks purchased

₹ 11.3 Cr

Volume Transacted

(Dec 11, 2024)

stocks purchased

1281.5 K

Stocks Traded

(Dec 11, 2024)

Last Updated on: Dec 12, 2024

Image

Morepen Laboratories Ltd

NSE: MOREPENLAB

PE

36.8

Last updated on: Dec 12, 2024

Key Highlights

  • The P/E Ratio of Morepen Laboratories Ltd is 36.8 as of 12 Dec 9.00 AM .
  • The P/E Ratio of Morepen Laboratories Ltd changed from 27 on March 2019 to 22.4 on March 2024 . This represents a CAGR of -3.06% over 6 years.
  • The Latest Trading Price of Morepen Laboratories Ltd is ₹ 88.37 as of 11 Dec 15:30 .
  • The PE Ratio of Pharmaceuticals Industry has changed from 28.2 to 27.1 in 5 years. This represents a CAGR of -0.79%.
  • The PE Ratio of Automobile industry is 20.3. The PE Ratio of Finance industry is 17.8. The PE Ratio of IT - Software industry is 30.5. The PE Ratio of Pharmaceuticals industry is 40.0. The PE Ratio of Retail industry is 157.6. The PE Ratio of Textiles industry is 37.6 in 2024.

Historical P/E Ratio of Morepen Laboratories Ltd

No data available

Company Fundamentals for Morepen Laboratories Ltd

No data available

Image

Morepen Laboratories Ltd

NSE: MOREPENLAB

Share Price

₹ 88.37

2.52 (2.94%)

stock direction

Last updated on: Dec 11, 2024

Market Price of Morepen Laboratories Ltd

1M

1Y

3Y

5Y

Monitoring Morepen Laboratories Ltd share price can help you stay informed about potential market shifts and opportunities. *All values are in Rupees.

Last Ten Days Market Price

Date
leftPrice (₹)right
11 Dec 202488.37
10 Dec 202485.85
09 Dec 202487.21
06 Dec 202487.22
05 Dec 202486.33
04 Dec 202486.33
03 Dec 202486
02 Dec 202484.01
29 Nov 202478.94
28 Nov 202477.9

SWOT Analysis Of Morepen Laboratories Ltd

Strength

2

S

Weakness

2

W

Opportunity

0

O

Threats

0

T

BlinkX Score for Morepen Laboratories Ltd

Revenue

Profitability

Affordability

Liquidity

Dividend

Asset Value vs Market Value of Morepen Laboratories Ltd

Market Value

0

Asset Value

0

* All values are in Rupees

Competitive Comparison of P/E Ratio

Company NamePEMarket Cap (INR Cr.)
Morepen Laboratories Ltd364,842
Sun Pharmaceuticals Industries Ltd384,35,407
Divis Laboratories Ltd851,57,489
Cipla Ltd251,17,443
Torrent Pharmaceuticals Ltd651,14,197
Mankind Pharma Ltd491,05,098

Key Valuation Metric of Morepen Laboratories Ltd

No data available

No data available

PE Ratio of Pharmaceuticals Industry over time

PE Ratio of Top Sectors

Historical Market Cap of Morepen Laboratories Ltd

No data available

* All values are in crore

Historical Revenue of Morepen Laboratories Ltd

No data available

* All values are in crore

Historical EBITDA of Morepen Laboratories Ltd

No data available

* All values are in crore

Historical Net Profit of Morepen Laboratories Ltd

No data available

* All values are in crore

Historical Dividend Payout of Morepen Laboratories Ltd

No data available

* All values are in %

About Morepen Laboratories Ltd

  • Morepen Laboratories Limited is an India-based pharmaceutical company.
  • Its products include Loratadine, Montelukast Sodium, Atorvastatin Calcium and Sultamicillin.
  • The company markets formulation products in various therapeutic categories, such as antibiotics, gastrointestinal, respiratory, analgesic, antiallergic and neuropsychiatry with brands, such as Saltum, Saltumax, Cefpopen, Cefpen-S, Dom-DT, Acifix, Rabipen- DSR and Montelast.
  • It has new products added to the therapeutic categories, including Kilbac, Ducal D, Aclomore and Montelast-L. The company has three state-of-the-art manufacturing plants in the northern state of Himachal Pradesh (HP) in India.
  • The main plant at Parwanoo is inspected and approved by United States Food and Drug Administration (USFDA) for production of Loratadine, which is the best selling anti-allergy drug globally.

Morepen Laboratories Ltd News Hub

News

Morepen Labs soars after stellar Q1 performance

Net revenue increased by 14% year-over-year (YoY) to Rs 458.64 crore during the period und...

Read more

2024-08-12 00:00:00

News

Morepen Laboratories consolidated net profit rises 147.23% in the June 2024 quarter

Net profit of Morepen Laboratories rose 147.23% to Rs 36.17 crore in the quarter ended Jun...

Read more

2024-08-12 00:00:00

News

Morepen Laboratories to announce Quarterly Result

Morepen Laboratories will hold a meeting of the Board of Directors of the Company on 12 Au...

Read more

2024-08-10 00:00:00

News

Morepen Laboratories successfully concludes QIP issue of Rs 200 cr

Morepen Laboratories announced the successful subscription of a Qualified Institutional Pl...

Read more

2024-08-06 00:00:00

Product Composition

Document

Annual Reports

N/A

dropdown
download

Credit Ratings

N/A

dropdown
download

Concalls

Data not available

FAQs for PE of Morepen Laboratories Ltd

What is the current PE Ratio of Morepen Laboratories Ltd?

The Current PE Ratio of Morepen Laboratories Ltd is 36.82 as on 12 Dec 2024.

What is the average PE Ratio of the Pharmaceuticals industry?

The average industry PE Ratio of Pharmaceuticals is 40.0 as on 12 Dec 2024.

What was the PE Ratio of Morepen Laboratories Ltd last year?

The PE Ratio of Morepen Laboratories Ltd was 33.79 last year, now the PE ratio is 36.82, showing a year-on-year growth of 9.0%.

What does the PE Ratio of Morepen Laboratories Ltd indicate about its stock?

The PE Ratio of Morepen Laboratories Ltd is 36.82. This ratio indicates that investors are willing to pay 36.82 times the earnings per share for each share of Morepen Laboratories Ltd.

What is the PE Ratio Growth of Morepen Laboratories Ltd in comparison to its Earnings per Share (EPS) growth rate?

The PE Ratio of Morepen Laboratories Ltd grew by 9.0% whereas, the EPS ratio grew by -8.5.
Disclaimer: This information provided above is for informational purposes only and does not constitute investment advice. We use third-party data and recommend conducting thorough research and consulting a certified financial advisor before making investment decisions. We do not endorse specific stocks. Make decisions based on your own research and professional guidance.
up arrow
Open Demat Account
Verify your phone
+91
*By signing up you agree to our terms & conditions